DK0534568T3 - Human væksthormon-mutanter og deres anvendelse - Google Patents
Human væksthormon-mutanter og deres anvendelseInfo
- Publication number
- DK0534568T3 DK0534568T3 DK92202956.6T DK92202956T DK0534568T3 DK 0534568 T3 DK0534568 T3 DK 0534568T3 DK 92202956 T DK92202956 T DK 92202956T DK 0534568 T3 DK0534568 T3 DK 0534568T3
- Authority
- DK
- Denmark
- Prior art keywords
- mutants
- amino acid
- growth hormone
- human growth
- hgh
- Prior art date
Links
- 102000002265 Human Growth Hormone Human genes 0.000 title abstract 5
- 108010000521 Human Growth Hormone Proteins 0.000 title abstract 5
- 239000000854 Human Growth Hormone Substances 0.000 title abstract 5
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 abstract 3
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 abstract 3
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 abstract 3
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 abstract 2
- 125000000539 amino acid group Chemical group 0.000 abstract 2
- 239000004475 Arginine Substances 0.000 abstract 1
- 208000010392 Bone Fractures Diseases 0.000 abstract 1
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 abstract 1
- 206010062767 Hypophysitis Diseases 0.000 abstract 1
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 abstract 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 abstract 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 abstract 1
- 235000019454 L-leucine Nutrition 0.000 abstract 1
- 239000004395 L-leucine Substances 0.000 abstract 1
- 229930182821 L-proline Natural products 0.000 abstract 1
- 239000004473 Threonine Substances 0.000 abstract 1
- 229960003767 alanine Drugs 0.000 abstract 1
- 150000001413 amino acids Chemical group 0.000 abstract 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 abstract 1
- 230000004071 biological effect Effects 0.000 abstract 1
- 230000004064 dysfunction Effects 0.000 abstract 1
- 230000007515 enzymatic degradation Effects 0.000 abstract 1
- 229960002885 histidine Drugs 0.000 abstract 1
- 229960003136 leucine Drugs 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
- 229960005190 phenylalanine Drugs 0.000 abstract 1
- 229960002429 proline Drugs 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 229960002898 threonine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI912582A IT1251895B (it) | 1991-09-27 | 1991-09-27 | Mutanti dell'ormone della crescita umano e loro impiego |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0534568T3 true DK0534568T3 (da) | 1996-07-15 |
Family
ID=11360779
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK92202956.6T DK0534568T3 (da) | 1991-09-27 | 1992-09-25 | Human væksthormon-mutanter og deres anvendelse |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0534568B1 (fr) |
| JP (1) | JPH05310794A (fr) |
| AT (1) | ATE138098T1 (fr) |
| DE (1) | DE69210733T2 (fr) |
| DK (1) | DK0534568T3 (fr) |
| ES (1) | ES2087434T3 (fr) |
| IT (1) | IT1251895B (fr) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0000837D0 (sv) | 2000-03-13 | 2000-03-13 | Pharmacia & Upjohn Ab | New use |
| JP2003079379A (ja) * | 2001-09-13 | 2003-03-18 | Itoham Foods Inc | 成長ホルモンの高発現用ｄｎａおよびその使用 |
| GB2384001B (en) * | 2001-12-14 | 2004-02-04 | Asterion Ltd | Chimeric growth hormone-growth hormone receptor proteins |
| CN102112157B (zh) | 2008-08-06 | 2013-05-29 | 诺沃-诺迪斯克保健股份有限公司 | 具有延长的体内效能的缀合蛋白 |
| CN102292349B (zh) | 2009-01-22 | 2016-04-13 | 诺沃—诺迪斯克保健股份有限公司 | 稳定的生长激素化合物 |
| US8841249B2 (en) | 2009-08-06 | 2014-09-23 | Novo Nordisk A/S | Growth hormones with prolonged in-vivo efficacy |
| TWI508737B (zh) | 2010-01-22 | 2015-11-21 | 諾佛 儂迪克股份有限公司 | 具有延長的活體內功效的生長激素 |
| US9211342B2 (en) | 2010-01-22 | 2015-12-15 | Novo Nordisk Healthcare Ag | Stable growth hormone compounds resistant to proteolytic degradation |
| US20130143815A1 (en) | 2010-07-22 | 2013-06-06 | Novo Nordisk Health Care Ag | Growth hormone conjugates |
| WO2014166836A1 (fr) | 2013-04-05 | 2014-10-16 | Novo Nordisk A/S | Formulation de composés d'hormone de croissance |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1223577B (it) * | 1987-12-22 | 1990-09-19 | Eniricerche Spa | Procedimento migliorato per la preparazione dell'ormone della crescita umano naturale in forma pura |
-
1991
- 1991-09-27 IT ITMI912582A patent/IT1251895B/it active IP Right Grant
-
1992
- 1992-09-25 AT AT92202956T patent/ATE138098T1/de not_active IP Right Cessation
- 1992-09-25 DE DE69210733T patent/DE69210733T2/de not_active Expired - Fee Related
- 1992-09-25 EP EP92202956A patent/EP0534568B1/fr not_active Expired - Lifetime
- 1992-09-25 ES ES92202956T patent/ES2087434T3/es not_active Expired - Lifetime
- 1992-09-25 DK DK92202956.6T patent/DK0534568T3/da active
- 1992-09-28 JP JP4281045A patent/JPH05310794A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| JPH05310794A (ja) | 1993-11-22 |
| EP0534568B1 (fr) | 1996-05-15 |
| EP0534568A2 (fr) | 1993-03-31 |
| ITMI912582A1 (it) | 1993-03-27 |
| DE69210733T2 (de) | 1996-10-02 |
| ATE138098T1 (de) | 1996-06-15 |
| DE69210733D1 (de) | 1996-06-20 |
| ES2087434T3 (es) | 1996-07-16 |
| EP0534568A3 (fr) | 1994-03-16 |
| IT1251895B (it) | 1995-05-26 |
| ITMI912582A0 (it) | 1991-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5470828A (en) | Peptide analogs of insulin-like growth factor II | |
| US5696089A (en) | Histidine substituted growth hormone releasing factor analogs | |
| DK162103B (da) | Syntetiske grf-analoge peptider og farmaceutisk acceptable salte heraf samt farmaceutisk middel indeholdende peptidet eller et ikke-toksisk salt deraf | |
| JPH0674279B2 (ja) | 成長ホルモン放出性因子類似体及びその製造方法 | |
| NL300013I1 (nl) | Nieuwe protein met TNF-remmende werking en hun ber | |
| MX9703643A (es) | Metodos para tratamiento de esclerosis multiple usando analogos de peptidos de proteina basica de mielina humana. | |
| FI842166A (fi) | Bukspottskoertelns grf hos maenniskan. | |
| HUP0004560A2 (hu) | Törést gyógyító PTHrP analógok | |
| KR900002801A (ko) | 당뇨병 치료용 약학적제제 | |
| DE68914205T2 (de) | Zyklische GRF-Analoge. | |
| DK0534568T3 (da) | Human væksthormon-mutanter og deres anvendelse | |
| AU6020099A (en) | Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein | |
| Carraway et al. | Structure of a biologically active neurotensin-related peptide obtained from pepsin-treated albumin (s). | |
| PT91631B (pt) | Processo para a preparacao de analogos de grf ciclicos | |
| DE69525544T2 (de) | Peptidanaloga des menschlichen myelinbasischen proteins mit substitution in position 91 zur behandlung von multipler sklerose | |
| DK384084A (da) | Vaeksthormonfrigoerende peptider samt fremgangsmaade til behandling af pattedyr hermed | |
| DK161096B (da) | Hpgrf-analoge peptider, ikke toksiske salte heraf og midlet indeholdende disse | |
| ATE377026T1 (de) | Behandlung von fettleibigkeit | |
| EP0264750A2 (fr) | Analogues du facteur libérant l'hormone de croissance | |
| JPH0786120B2 (ja) | ポリペプチド | |
| CA2248630A1 (fr) | Peptides et pseudopeptides synthetiques possedant une activite osteogenique et compositions pharmaceutiques les contenant | |
| DE69025123T2 (de) | Grf-viia-analoge | |
| JP2715472B2 (ja) | 環式ペプチド | |
| HU0102043D0 (en) | Pharmaceutical compounds which interact with an ca2+ channel alpha2delta subunit | |
| RU99116976A (ru) | Миелопептиды и их терапевтическое использование |